{"id":"CHEMBL1091250","canonicalSmiles":"O=C1/C(=C2\\Nc3ccc(S(=O)(=O)O)cc3C2=O)Nc2ccc(S(=O)(=O)O)cc21","inchiKey":"CFZXDJWFRVEWSR-BUHFOSPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIGOTINDISULFONATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5,5'-indigotindisulfonic acid","Blue x","Indigo carmine acid","Indigotindisulfonate","Indigotindisulfonic acid","NSC-8646","Saxon blue"],"crossReferences":{"PubChem":["144206720","144206721"],"drugbank":["DB11577"],"chEBI":["90117"]},"childChemblIds":["CHEMBL2105023"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1097279","canonicalSmiles":"CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+]","inchiKey":"COWWROCHWNGJHQ-OPKBHZIBSA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"CANGRELOR TETRASODIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL334966","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kengreal"],"synonyms":["AR-C69931MX","Cangrelor","Cangrelor tetrasodium","Cangrelor tetrasodium salt","Kengrexal"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0008585","EFO_0000612","HP_0004419"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for recurrent thrombophlebitis and myocardial infarction."}
{"id":"CHEMBL109831","canonicalSmiles":"Nc1nc(=O)n([C@H]2C=C[C@@H](CO)O2)cc1F","inchiKey":"HSBKFSPNDWWPSL-CAHLUQPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXELVUCITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Reverset"],"synonyms":["DPC-817","Dexelvucitabine","INCB-8721","YZ-817"],"crossReferences":{"drugbank":["DB12470"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL113313","canonicalSmiles":"CN1N=C2CCN(C(=O)[C@@H](COCc3ccccc3)NC(=O)C(C)(C)N)C[C@@]2(Cc2ccccc2)C1=O","inchiKey":"KVLLHLWBPNCVNR-SKCUWOTOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPROMORELIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-424,391","CP-424391-18","Capimorelin","Capromorelin","Cp-424,391","Cp-424391"],"crossReferences":{"Wikipedia":["Capromorelin"],"drugbank":["DB15205"]},"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["GO_0007568"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1160597","canonicalSmiles":"Cc1cn([C@H]2C[C@H](N)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"BQZMHQZNZNBJNF-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160597","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03233"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1187","canonicalSmiles":"O=P(O)(O)O","inchiKey":"NBIIXXVUZAFLBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHORIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acidum phosphoricum","Amberphos 54","E 338","E-338","E338","FEMA NO. 2900","INS NO.338","INS-338","NSC-80804","Phosphoric Acid","Phosphoric acid","Phosphoricum acidum","Vococid","Wc-reiniger","Y-11A06"],"crossReferences":{"DailyMed":["phosphoric%20acid"],"PubChem":["144204604","144209483","144213563","17388778"],"Wikipedia":["Phosphoric_acid"],"drugbank":["DB09394"],"chEBI":["26078"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200338","canonicalSmiles":"CC(N/C(=N\\C#N)Nc1ccncc1)C(C)(C)C.O","inchiKey":"AFJCNBBHEVLGCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINACIDIL","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1159","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pindac"],"synonyms":["NSC-759588","Pinacidil","Pinacidil hydrate","Pinacidil monohydrate"],"crossReferences":{"PubChem":["144204505","170465261","56462991"],"Wikipedia":["Pinacidil"],"chEBI":["34923"]},"linkedTargets":{"rows":["ENSG00000069431"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for hypertension."}
{"id":"CHEMBL1200455","canonicalSmiles":"CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"NTHXOOBQLCIOLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOHEXOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exypaque","Omnipaque","Omnipaque 12","Omnipaque 140","Omnipaque 180","Omnipaque 210","Omnipaque 240","Omnipaque 300","Omnipaque 350","Omnipaque 70","Omnipaque 9","Oraltag"],"synonyms":["Iohexol","Iohexolum","NSC-759636","WIN 39424","WIN-39424"],"crossReferences":{"DailyMed":["iohexol"],"PubChem":["144205839","170464962","29217758","56322616"],"Wikipedia":["Iohexol"],"drugbank":["DB01362"],"chEBI":["31709"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200604","canonicalSmiles":"CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1","inchiKey":"BGDKAVGWHJFAGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROPICAMIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mydriacyl","Mydriafair","Nods","Tropicacyl","Tropicamide"],"synonyms":["Bistropamide","NSC-757372","RO-1-7683","Tropicamide","Tropicamidum","Visumidriatic"],"crossReferences":{"DailyMed":["tropicamide"],"PubChem":["104171259","144203848","170464754","26747134","50086517","50104635","85231280","90341160"],"Wikipedia":["Tropicamide"],"drugbank":["DB00809"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["MONDO_0001330","EFO_0003966","EFO_0005758","MONDO_0005180","HP_0000545","HP_0002307","HP_0011499","EFO_1001158"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for mydriasis and has 4 investigational indications."}
{"id":"CHEMBL1200981","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.Cl","inchiKey":"MWWSFMDVAYGXBV-FGBSZODSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"EPIRUBICIN HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL417","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ellence","Epirubicin hydrochloride","Farmorubicin","Pharmorubicin"],"synonyms":["Epirubicin hcl","Epirubicin hydrochloride","Farmorubicina","IMI-28","NSC-759195","WP-697"],"crossReferences":{"DailyMed":["epirubicin%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 4 approved and 29 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201103","canonicalSmiles":"COc1ccc(OC)c(C(O)C(C)N)c1.Cl","inchiKey":"YGRFXPCHZBRUKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOXAMINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL524","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vasoxine","Vasoxyl"],"synonyms":["Methoxamine hcl","Methoxamine hydrochloride","NSC-757102"],"crossReferences":{"PubChem":["144204799","26747569","50106595","56422119","855753"]},"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0009523"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1201201","canonicalSmiles":"CN[C@@H](C)Cc1ccccc1","inchiKey":"MYWUZJCMWCOHBA-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHAMPHETAMINE","yearOfFirstApproval":1943,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["(s)-phenylmethylaminopropane","J6.362B","Metamfetamine","Methamphetamine","NSC-25115"],"crossReferences":{"DailyMed":["methamphetamine%20hydrochloride"],"Wikipedia":["Methamphetamine"],"drugbank":["DB01577"],"chEBI":["6809"]},"childChemblIds":["CHEMBL1200952"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0004701"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1943 and is indicated for attention deficit hyperactivity disorder and has 1 investigational indication. It was withdrawn in United States. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201346","canonicalSmiles":"O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1","inchiKey":"IPOKCKJONYRRHP-FMQUCBEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALSALAZIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Balsalazide"],"crossReferences":{"DailyMed":["balsalazide%20disodium"],"PubChem":["144205805","170465305","26758056"],"drugbank":["DB01014"],"chEBI":["267413"]},"childChemblIds":["CHEMBL1200760"],"linkedTargets":{"rows":["ENSG00000132170","ENSG00000012779","ENSG00000073756","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","HP_0004798"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000 and is indicated for ulcerative colitis."}
{"id":"CHEMBL1201577","drugType":"Antibody","blackBoxWarning":true,"name":"CETUXIMAB","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erbitux"],"synonyms":["ABP-494","C-225","C225","CMAB-009","CMAB009","Cetuximab","Cetuximab (genetical recombination)","Cetuximab biosimilar (abp-494)","IMC-225","IMC-C225","MOAB C225"],"crossReferences":{"DailyMed":["cetuximab"],"DrugCentral":["4954"],"Wikipedia":["Cetuximab"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003891","EFO_0000365","EFO_0000571","EFO_1000657","EFO_0000228","MONDO_0044704","EFO_1001951","MONDO_0002358","Orphanet_178","MONDO_0021310","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0000182","MONDO_0002038","MONDO_0018352","EFO_0002618","EFO_1001931","EFO_0005922","MONDO_0008170","EFO_0005842","MONDO_0008315","EFO_0005221","MONDO_0001879","EFO_0009708","EFO_1001967","MONDO_0002691","EFO_0001061","MONDO_0044787","EFO_0003868","MONDO_0001023","EFO_1001100","EFO_0004284","EFO_0000233","EFO_0001378","EFO_0003835","MONDO_0021355","EFO_1000172","EFO_1001998","EFO_0002938","MONDO_0100342","MONDO_0007254","EFO_0003871","EFO_0004252","MONDO_0021063","MONDO_0002087","EFO_0000231","MONDO_0001187","EFO_0003817","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0021364","EFO_0009430","EFO_0006352","MONDO_0001657","EFO_0000673","EFO_0002499","EFO_0000707","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","EFO_0000503","EFO_0000478","MONDO_0007576","EFO_0000313","EFO_0004198","EFO_0007535","EFO_0003060","EFO_0000311","MONDO_0002529","MONDO_0011962","EFO_0004142","MONDO_0024880","EFO_1001950","EFO_0000181","EFO_0000691","EFO_0000519","MONDO_0044926"],"count":81},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 12 approved and 59 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201595","drugType":"Enzyme","blackBoxWarning":true,"name":"LARONIDASE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldurazyme"],"synonyms":["A-l-iduronidase","Alronidase","Ec 3.2.1.76","Laronidase"],"crossReferences":{"DailyMed":["laronidase"],"DrugCentral":["4997"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for mucopolysaccharidosis and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1230961","canonicalSmiles":"CN[C@@H]1[C@@H](O[C@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O)O[C@H]2C[C@@H](N)[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)O[C@@H]2[C@@H]1O","inchiKey":"XZNUGFQTQHRASN-XQENGBIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Apramycin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apramycin"],"crossReferences":{"PubChem":["144204190"],"Wikipedia":["Apramycin"],"drugbank":["DB04626"],"chEBI":["2790"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232445","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@H]2O","inchiKey":"PROQIPRRNZUXQM-PNVOZDDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"17-Epiestriol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["17-Epiestriol"],"crossReferences":{"drugbank":["DB07702"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232583","canonicalSmiles":"COc1ccc(S(=O)(=O)n2cc(CCC(=O)O)c3cc(OC)ccc32)cc1","inchiKey":"YMPALHOKRBVHOJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDEGLITAZAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indeglitazar","PPM-204"],"crossReferences":{"drugbank":["DB07724"]},"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951","ENSG00000132170"],"count":3},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1232673","canonicalSmiles":"NS(=O)(=O)c1ccc(F)cc1","inchiKey":"LFLSATHZMYYIAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Fluorobenzenesulfonamide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Fluorobenzenesulfonamide"],"crossReferences":{"drugbank":["DB01784"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232973","canonicalSmiles":"O=C(O)c1nsnc1O","inchiKey":"FVZITYNLUYJDOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232973","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03162"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234270","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NC[C@@H]1CN(c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)CN21","inchiKey":"QYNUQALWYRSVHF-OLZOCXBDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARFOLITIXORIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Modufolin"],"synonyms":["6r-mthf","Arfolitixorin","ISO-901","Modufolin","[6R]-5,10-methylenetetrahydrofolate ([6R]-5,10- MTHF)"],"crossReferences":{"drugbank":["DB12676"],"chEBI":["1989"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1234781","canonicalSmiles":"O=C(O)COc1cccc2ccccc12","inchiKey":"GHRYSOFWKRRLMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAPHTHYLOXYACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["14739759"],"drugbank":["DB08286"],"chEBI":["44588"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236068","canonicalSmiles":"CNC(=O)[C@@H](C)[C@H]1C(=O)/C(=C(O)/C=C/C(C)=C/[C@@H](C)[C@H]2O[C@@]3(C)O[C@H](C=C[C@@]34CO4)[C@@H]2C)C(=O)N1[C@@H]1CC[C@H](O)[C@H](C)O1","inchiKey":"KVTPRMVXYZKLIG-NCAOFHFGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTOLYDIGIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Streptolydigin"],"drugbank":["DB04785"],"chEBI":["45773"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1289","canonicalSmiles":"Clc1cc(Cl)c(OCC#CI)cc1Cl","inchiKey":"CTETYYAZBPJBHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOPROGIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Halotex","Mycanden"],"synonyms":["Haloprogin","M-1028","NSC-100071"],"crossReferences":{"PubChem":["144206294","225144320","50125846"],"Wikipedia":["Haloprogin"],"drugbank":["DB00793"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL13","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1","inchiKey":"IUBSYMUCCVWXPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOPROLOL","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(rs)-metoprolol","Beatrolol","CGP-2175","Dl-metoprolol","Lopressidone","Metoprolol","Metoprolol slow release","Seroken","Toprol-XL"],"crossReferences":{"DailyMed":["metoprolol%20succinate","metoprolol%20tartrate"],"PubChem":["251919670"],"Wikipedia":["Metoprolol"],"drugbank":["DB00264"],"chEBI":["6904"]},"childChemblIds":["CHEMBL1200337","CHEMBL1200840","CHEMBL2062335","CHEMBL545787","CHEMBL3186768","CHEMBL2356097","CHEMBL3989566","CHEMBL1868892"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","EFO_0000318","EFO_0004278","EFO_0005252","MONDO_0007254","EFO_0000373","Orphanet_848","EFO_0000266","EFO_0000538","EFO_0000274","EFO_0009094","EFO_0007148","EFO_0003913","EFO_0003914","EFO_0003911","Orphanet_739","EFO_0008585","EFO_0003144","EFO_0000712","EFO_0005306","EFO_0000676","EFO_0003917","EFO_0009321","EFO_0000400","EFO_0000407","EFO_0008586","HP_0001653","EFO_0000616","HP_0003124","EFO_0004269","EFO_0001645","EFO_1001466","EFO_0000319","MONDO_0024361","EFO_0001073","EFO_0000537","Orphanet_98896","EFO_0000195","MONDO_0001134","EFO_1000391","EFO_0001068","Orphanet_79292","EFO_0004287","EFO_0000764","HP_0004308","EFO_0008583","EFO_0000612","EFO_0000341","MONDO_0005148","HP_0012594","EFO_0005672","EFO_0005251"],"count":53},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 7 approved and 33 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1306","canonicalSmiles":"CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1","inchiKey":"BLSQLHNBWJLIBQ-OZXSUGGESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERCONAZOLE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fungistat","Gyno-Terazol","Panlomyc","Terazol","Terazol 3","Terazol 7","Terconazole","Triaconazole"],"synonyms":["Fungistat","NSC-331942","R 42470","R-42,470","R-42470","Terconazole","Tercospor","Termayazole","Triaconazole"],"crossReferences":{"DailyMed":["terconazole"],"PubChem":["144204230","56463234"],"Wikipedia":["Terconazole"],"drugbank":["DB00251"],"chEBI":["82980"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 2 investigational indications."}
{"id":"CHEMBL142464","canonicalSmiles":"CCNCCCNC/C=C\\CNCCCNCC","inchiKey":"XFWLTFZLLXVKDY-WAYWQWQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CGC-11047","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGC-11047","Cgc-11047","SL 11047","SL 47"],"childChemblIds":["CHEMBL3104344","CHEMBL4296681"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1561","canonicalSmiles":"OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO","inchiKey":"IBAQFPQHRJAVAV-ULAWRXDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIGLITOL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diastabol","Glyset","Miglitol"],"synonyms":["BAY M 1099","BAY-M-1099","Miglitol","NSC-758702"],"crossReferences":{"DailyMed":["miglitol"],"PubChem":["144204989","170465326","26719889","49681630"],"Wikipedia":["Miglitol"],"drugbank":["DB00491"],"chEBI":["6935"]},"linkedTargets":{"rows":["ENSG00000257335","ENSG00000171298"],"count":2},"linkedDiseases":{"rows":["MONDO_0005147","MONDO_0005148","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 1 investigational indication."}
{"id":"CHEMBL160038","canonicalSmiles":"O=C(Cc1ccccc1)c1cc(O)c(O)c([N+](=O)[O-])c1","inchiKey":"MRFOLGFFTUGAEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBICAPONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nebicapone"],"crossReferences":{"drugbank":["DB14849"]},"linkedTargets":{"rows":["ENSG00000093010"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1611","canonicalSmiles":"O=C1N=C([O-])NC1(c1ccccc1)c1ccccc1.[Na+]","inchiKey":"FJPYVLNWWICYDW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"PHENYTOIN SODIUM","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL16","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dilantin","Diphenylan sodium","Extended phenytoin sodium","Pentran","Phenytek","Phenytex","Phenytoin sodium","Prompt phenytoin sodium"],"synonyms":["Antisacer","Diphenylhydantoin sodium","NSC-757274","Phenytoin Sodium","Phenytoin sodium","Phenytoin sodium extended","Phenytoin sodium for injection","Phenytoin sodium salt","Phenytoin sodium, extended","Phenytoin sodium, prompt","Phenytoin sodium,extended","Phenytoin sodium,prompt","Phenytoinum natricum","Tacosal"],"crossReferences":{"DailyMed":["phenytoin%20sodium"],"PubChem":["11112021","144212655","14742085","26757853","50106089","85231301","855788"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956. This drug has a black box warning from the FDA."}
{"id":"CHEMBL162036","canonicalSmiles":"CC(=O)Nc1ccc(OC(=O)c2ccccc2OC(C)=O)cc1","inchiKey":"FEJKLNWAOXSSNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENORILATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benoral","Triadol"],"synonyms":["Benorilate","Benorylate","Fenasprate","WIN 11450","WIN-11450"],"crossReferences":{"PubChem":["144206025","170466237","50112722"],"Wikipedia":["Benorilate"],"drugbank":["DB13657"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever."}
{"id":"CHEMBL1632","canonicalSmiles":"CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1.[Na+]","inchiKey":"VUFGUVLLDPOSBC-XRZFDKQNSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALOTHIN SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL617","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Averon","Cefalotin","Cephalothin","Cephalothin sodium","Keflin","Seffin","Synclotin","Toricelocin"],"synonyms":["38253","Cefalotin sodium","Cephalothin sodium","Cephalothin sodium salt","NSC-756667","Sodium cephalothin"],"crossReferences":{"PubChem":["50106038","855938"],"chEBI":["3542"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1644695","canonicalSmiles":"[I-].[Na+]","inchiKey":"FVAUCKIRQBBSSJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM IODIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fdy-5301","Iodide (as sodium iodide)","NSC-77388","Sodium iodide"],"crossReferences":{"DailyMed":["sodium%20iodide%20i-123","sodium%20iodide%20i-131"],"PubChem":["144211696"],"Wikipedia":["Sodium_iodide"],"drugbank":["DB11119"],"chEBI":["33167"]},"childChemblIds":["CHEMBL1201083","CHEMBL3707217","CHEMBL1201084","CHEMBL2105877"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1655","canonicalSmiles":"CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1","inchiKey":"XFCLJVABOIYOMF-QPLCGJKRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOREMIFENE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acapodene","Chlortamoxifen","Farestone","GTX-006","J33.157K","Toremifene","Toremiphene"],"crossReferences":{"DailyMed":["toremifene%20citrate"],"PubChem":["29216214"],"Wikipedia":["Toremifene"],"drugbank":["DB00539"],"chEBI":["9635"]},"childChemblIds":["CHEMBL1200675"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0003931","MONDO_0100096","MONDO_0004658","EFO_1001366","MONDO_0008170","EFO_0009907","MONDO_0007254","EFO_0002621","EFO_0003882","EFO_0000305","MONDO_0008315"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 4 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1684590","canonicalSmiles":"C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@H]1C","inchiKey":"WYQVAPGDARQUBT-FGWHUCSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1684590","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14081"],"chEBI":["79928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697768","canonicalSmiles":"O=S(=O)([O-])Oc1ccc(C(c2ccc(OS(=O)(=O)[O-])cc2)c2ccccn2)cc1.[Na+].[Na+]","inchiKey":"GOZDTZWAMGHLDY-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PICOSULFATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1741134","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citrafleet","Dulcolax pico","Otc concepts","Picolax"],"synonyms":["DA 1773","DA-1773","Guttalax-fher","LA 391","LA-391","Laxoberal","Laxoberon","Neopax","Pico-salax","Picosulfate sodium","Picosulfate sodium anhydrous","Picosulfate sodium hydrate","Sodium picosulfate","Sodium picosulfate anhydrous","Sodium picosulfate hydrate","Sodium picosulfate monohydrate","Sodium picosulphate","Sodium picosulphate anhydrous","Sodium picosulphate monohydrate"],"crossReferences":{"DailyMed":["sodium%20picosulfate"],"DrugCentral":["4779"],"PubChem":["144206577"],"chEBI":["32147"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for constipation."}
{"id":"CHEMBL1697782","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"DALKLAYLIPSCQL-YPYQNWSCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE ACEPONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Advantan"],"synonyms":["Methylprednisolone aceponate"],"crossReferences":{"drugbank":["DB14643"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1697829","canonicalSmiles":"O=C(Cn1cnnn1)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nncs3)CS[C@H]12","inchiKey":"DZMVCVMFETWNIU-LDYMZIIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTEZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ceftezole","Ceftezole sodium","J01DB12"],"crossReferences":{"drugbank":["DB13821"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1742994","drugType":"Antibody","blackBoxWarning":true,"name":"BRENTUXIMAB VEDOTIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adcetris"],"synonyms":["Brentuximab vedotin","Brentuximab vedotin brentuximab","CAC-10","CAC10","CAC10-VCMMAE","Cac10-1006(4)","Cac10-vcmmae(4)","Monoclonal antibody sgn-30","SGN-35"],"crossReferences":{"DailyMed":["brentuximab%20vedotin"],"DrugCentral":["4964"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000120949","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["MONDO_0009348","EFO_0004708","MONDO_0019471","EFO_0002913","EFO_0005952","EFO_0000565","EFO_0000588","EFO_0000096","EFO_0002690","EFO_0000514","EFO_0000183","EFO_1000785","MONDO_0013730","EFO_0000616","EFO_0001642","EFO_0000403","EFO_0000222","EFO_0004599","EFO_0000211","EFO_0000404","EFO_0003032","EFO_0000095","EFO_0007359","EFO_0000764","EFO_0000574","MONDO_0019473","MONDO_0018906","EFO_1001051"],"count":28},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 4 approved and 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1749","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)O)CC(=O)O.[Na+].[Na+]","inchiKey":"ZGTMUACCHSMWAC-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"EDETATE DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Disodium Edetate","Edetate Disodium","Endrate","Sodium Versenate"],"synonyms":["Disodium edetate dihydrate","Disodium edetate hydrate","E386","Edetate Disodium","Edta disodium salt","Edta disodium salt anhydrous","NSC-2760","NSC-759604","Sodium Edetate"],"crossReferences":{"DrugCentral":["4708"],"drugbank":["DB14600"],"chEBI":["64734"]},"childChemblIds":["CHEMBL3989507"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for eye disease and has 4 investigational indications."}
{"id":"CHEMBL189558","canonicalSmiles":"O=C1N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]1Cc1ccc(O)cc1","inchiKey":"NGPCLOGFGKJCBP-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Cyclo(-Trp-Tyr)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclo(-Trp-Tyr)"],"crossReferences":{"drugbank":["DB08761"],"chEBI":["65063"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950289","canonicalSmiles":"O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1","inchiKey":"IBGLGMOPHJQDJB-IHRRRGAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANZISERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-930","JNK 930","JNK-930","Tanzisertib"],"crossReferences":{"drugbank":["DB11798"]},"linkedTargets":{"rows":["ENSG00000107643","ENSG00000050748","ENSG00000109339"],"count":3},"linkedDiseases":{"rows":["MONDO_0004670","EFO_0000768"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL19612","canonicalSmiles":"NCCCCNCCCN","inchiKey":"ATHGHQPFGPMSJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPERMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Spermidine"],"crossReferences":{"PubChem":["11111787","11113819","124881418","90340561"],"Wikipedia":["Spermidine"],"drugbank":["DB03566"],"chEBI":["16610"]},"childChemblIds":["CHEMBL1256356","CHEMBL1473196"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2009034","canonicalSmiles":"O=S(=O)(O)CCSSCCS(=O)(=O)O","inchiKey":"BYUKOOOZTSTOOH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMESNA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimesna"],"childChemblIds":["CHEMBL2104318","CHEMBL2028409"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL206031","canonicalSmiles":"Cc1nc(COc2ccc(C[C@H](NC(=O)O[C@H]3CO[C@H]4OCC[C@@H]34)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1","inchiKey":"JORVRJNILJXMMG-OLNQLETPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRECANAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brecanavir","GW-640385","GW-640385X","GW-64085X","GW640385","GW64085X"],"crossReferences":{"Wikipedia":["Brecanavir"],"drugbank":["DB04887"]},"childChemblIds":["CHEMBL2377051","CHEMBL2377050"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104292","canonicalSmiles":"C#CCC1(OC(N)=O)CCCCC1","inchiKey":"MIRHIEAGDGUXKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAPROPYMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexapropymate","Merinax","NSC-169094"],"crossReferences":{"drugbank":["DB13662"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105420","canonicalSmiles":"O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1","inchiKey":"AJKIRUJIDFJUKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAUROLIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(cyclo)-taurolidine","Cyclo-taurolidine","Taurolidine","W-3100M"],"crossReferences":{"drugbank":["DB12473"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2105618","canonicalSmiles":"C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCCC4[C@H]3CC[C@@]21C","inchiKey":"ATXHVCQZZJYMCF-XZCODKSBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLYLESTRENOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gestanin"],"synonyms":["Allylestrenol","Allyloestrenol","NSC-37723","Perselin"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2105664","canonicalSmiles":"CC(OC(=O)c1ccc(Cc2c(O)c3ccccc3oc2=O)cc1)(C(F)(F)F)C(F)(F)F","inchiKey":"QFLNTQDOVCLQKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECARFARIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-5923","Tecarfarin"],"crossReferences":{"drugbank":["DB12823"]},"childChemblIds":["CHEMBL2105676"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107301","canonicalSmiles":"CC(C)[C@H](N)C(=O)OCC[C@@H](CO)Cn1cnc2c(=O)[nH]c(N)nc21","inchiKey":"ATSZELKUSAREPW-ZJUUUORDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALOMACICLOVIR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EPB-348","Valomaciclovir"],"crossReferences":{"drugbank":["DB06575"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107384","canonicalSmiles":"COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C.O=C(O)/C=C\\C(=O)O","inchiKey":"GXINKQQWHLIBJA-UCIBKFKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VICRIVIROC MALEATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL82301","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-4176","SCH 417690","SCH-417690","Sch417690","Vicriviroc maleate"],"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108707","drugType":"Antibody","blackBoxWarning":false,"name":"GLEMBATUMUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-011","CR011","CR011-VCMMAE","Glembatumumab"],"linkedTargets":{"rows":["ENSG00000136235"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","MONDO_0007254"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109050","drugType":"Unknown","blackBoxWarning":false,"name":"LAUROMACROGOL 400","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lauromacrogol","Lauromacrogol 400","Polyoxyl 9 lauryl ether"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109128","drugType":"Protein","blackBoxWarning":false,"name":"LENOGRASTIM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Granocyte-13","Granocyte-34"],"synonyms":["G-csf (cho cell derived)","Glycosylated recombinant g-csf","Granocyte","Granulocyte colony-stimulating factor lenograstim","Lenograstim","Lenograstim (genetical recombination)","Lenograstim rdna","Neutrogin","RG-CSF"],"crossReferences":{"DrugCentral":["5167"]},"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000403","EFO_0008583","EFO_0000222","EFO_0001378","MONDO_0008315"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109455","drugType":"Antibody","blackBoxWarning":false,"name":"AL-901","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-901"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109553","drugType":"Antibody","blackBoxWarning":false,"name":"CYT-500 177LU","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYT-500","Cyt-500 177lu"],"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["EFO_0000196"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110666","canonicalSmiles":"N#C[C@@H]1C[C@H](F)CN1C(=O)[C@@H](N)C(c1ccc(F)cc1)c1ccc(F)cc1","inchiKey":"URRAHSMDPCMOTH-LNLFQRSKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DENAGLIPTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denagliptin"],"childChemblIds":["CHEMBL2104962"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 1 investigational indication."}
{"id":"CHEMBL222287","canonicalSmiles":"CC[C@H]1C[C@H]2C[C@H]3c4[nH]c5ccc(OC)cc5c4CCN(C2)[C@@H]13","inchiKey":"HSIBGVUMFOSJPD-NXWOVTFFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBOGAINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-ibogaine","10-Methoxyibogamine","12-methoxyibogamine","Ibogaine","Ibogamine, 12-methoxy-","NSC-249764"],"crossReferences":{"chEBI":["5852"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL227875","canonicalSmiles":"O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2","inchiKey":"ZLHZLMOSPGACSZ-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRETOMANID","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["PA 824","PA-824","PA824","Pretomanid"],"crossReferences":{"DailyMed":["pretomanid"],"Wikipedia":["PA_824"],"drugbank":["DB05154"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for tuberculosis and pulmonary tuberculosis and has 2 investigational indications."}
{"id":"CHEMBL235668","canonicalSmiles":"N=C1CCCN1Cc1nc(O)nc(O)c1Cl","inchiKey":"QQHMKNYGKVVGCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIPIRACIL","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["MA-1","TPI (freebase)","Tipiracil"],"crossReferences":{"DailyMed":["tipiracil%20hydrochloride"],"drugbank":["DB09343"]},"childChemblIds":["CHEMBL65375"],"linkedTargets":{"rows":["ENSG00000025708"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0003869","EFO_0000365","EFO_0004142","EFO_0005842","EFO_1000657","MONDO_0007254","MONDO_0021063","MONDO_0044937","EFO_0005221","EFO_1001951"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for colorectal adenocarcinoma and has 8 investigational indications."}
{"id":"CHEMBL236345","canonicalSmiles":"Cn1cc(NC(=O)c2cc(NC(=O)c3ccc(/C=C/c4cnc5ccccc5c4)cc3)cn2C)cc1C(=O)NCCN1CCOCC1","inchiKey":"OEKXCVYZBVOWBR-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MGB-BP-3","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.725.402K","MGB-BP-3","Mgb-bp-3","Mgb-bp3"],"crossReferences":{"drugbank":["DB12892"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2381408","canonicalSmiles":"CC(C)(C)C[C@@H]1N[C@@H](C(=O)N[C@H]2CC[C@H](O)CC2)[C@H](c2cccc(Cl)c2F)[C@]12C(=O)Nc1cc(Cl)ccc12","inchiKey":"IDKAKZRYYDCJDU-HBMMIIHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-405838","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MI-77301","SAR405838","Sar 405838","Sar-405838","Sar405838"],"crossReferences":{"drugbank":["DB12541"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL242080","canonicalSmiles":"CC(C)(C)c1cc(O)ccc1O","inchiKey":"BGNXCDMCOKJUMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E319","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E319"],"crossReferences":{"PubChem":["104171088","144203557","144203558","144209507","144210401","17388706","17390000","26752804","4252498","50105455","71164"],"Wikipedia":["Tert-Butylhydroquinone"],"drugbank":["DB07726"],"chEBI":["78886"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL244342","canonicalSmiles":"CN(C(=O)CCN1Cc2cc(C(=O)c3ccccc3)ccc2N=C1N)C1CCCCC1","inchiKey":"KTRFBFMYAJOXLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL244342","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08749"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL251429","canonicalSmiles":"Nc1nc(N)c2c(OCC3CCN(Cc4ccccc4F)CC3)cccc2n1","inchiKey":"GYKIQIOWVKCVBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL251429","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["99367985"],"drugbank":["DB07642"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272557","canonicalSmiles":"Nc1nc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I","inchiKey":"GIMSJJHKKXRFGV-BYPJNBLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIACITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fiac","Fiacitabine","NSC-382097"],"crossReferences":{"PubChem":["170466497"],"drugbank":["DB12901"]},"childChemblIds":["CHEMBL3228488"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL298737","canonicalSmiles":"Cn1c(=O)c2nc(N)[nH]c2n(C)c1=O","inchiKey":"ZZESAIGPDOBLKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL298737","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01778"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29919","canonicalSmiles":"Nc1cnc(-c2cc(Cl)cc(Cl)c2Cl)c(N)n1","inchiKey":"NNXUYJFHOVCRSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELPETRIGINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elpetrigine","JZP-4"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL304784","canonicalSmiles":"CCCC[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O","inchiKey":"FMYKJLXRRQTBOR-BZSNNMDCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL304784","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26755321","26755322"],"drugbank":["DB07558"],"chEBI":["2423"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3092562","canonicalSmiles":"Cc1nc(-c2cnn(C)c2-c2ccc(C(F)(F)F)cn2)c2c(N3CCC3)ncnn12","inchiKey":"CLGCHUKGBICQTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05180999","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05180999","PF-999","Pf-05180999"],"crossReferences":{"drugbank":["DB14885"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL311498","canonicalSmiles":"Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@@H](O)C2","inchiKey":"PFTAWBLQPZVEMU-DZGCQCFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIANIDANOL","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"," Germany"," France"," Switzerland"],"classes":["Hematological toxicity"],"year":1985},"tradeNames":[],"synonyms":["Catechin","Catechin, d-","Catechinic acid","Catechuic acid","Catergen","Cianidanol","Cianidol","D-catechol","NSC-2819"],"crossReferences":{"PubChem":["11113249","26753531","50105958","69414","85231341","90341637"],"drugbank":["DB14086"],"chEBI":["15600"]},"childChemblIds":["CHEMBL1256783"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977. It was withdrawn in Spain,  Germany,  France and  Switzerland initially in 1985 due to Hematological toxicity."}
{"id":"CHEMBL3544944","canonicalSmiles":"O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12","inchiKey":"JJWLXRKVUJDJKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-863233","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3544943"],"linkedTargets":{"rows":["ENSG00000097046"],"count":1},"linkedDiseases":{"rows":["MONDO_0004111","MONDO_0024880"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3544981","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc([N+](=O)[O-])ccc2OCC[C@@H](C(=O)NCC(=O)O)NC1=O","inchiKey":"DVJXNXPFYJIACK-ULQDDVLXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TAVILERMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MIM-D3","Tavilermide"],"crossReferences":{"drugbank":["DB12441"]},"childChemblIds":["CHEMBL3545067"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545053","drugType":"Small molecule","blackBoxWarning":false,"name":"EMD-1204831","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emd-1204831"],"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545143","drugType":"Small molecule","blackBoxWarning":false,"name":"SR-13668","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SR13668","Sr-13668"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545305","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O","inchiKey":"WZTIQQBMSJTRBR-WYKNNRPVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CIBINETIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARA 290","ARA-290","ARA290","Ara 290","Ara290","Cibinetide","Ph-bsp","Phbsp"],"crossReferences":{"drugbank":["DB13006"]},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545328","canonicalSmiles":"O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1","inchiKey":"ISOCDPQFIXDIMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XL-019","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["XL019","Xl-019"],"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["MONDO_0044903","EFO_0002429","EFO_0000479"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545330","canonicalSmiles":"c1cnc(NCc2ccc(CNc3ncccn3)cc2)nc1","inchiKey":"PXZXYRKDDXKDTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MSX-122","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Msx 122","Msx-122"],"crossReferences":{"drugbank":["DB12715"]},"linkedTargets":{"rows":["ENSG00000121966"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545427","drugType":"Small molecule","blackBoxWarning":false,"name":"CM-082","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cm-082"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000113721","ENSG00000157404","ENSG00000122025"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","MONDO_0000544","EFO_0001365","EFO_0000681","EFO_0000702","EFO_0003060","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3707400","drugType":"Small molecule","blackBoxWarning":false,"name":"INDANTADOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chf-3381 free base","Chf3381","Indantadol","V3381"],"linkedTargets":{"rows":["ENSG00000161509","ENSG00000273079","ENSG00000116032","ENSG00000183454","ENSG00000189221","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":8},"linkedDiseases":{"rows":["EFO_0005762","EFO_1000783","HP_0012735","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3989406","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O","inchiKey":"MZYVOFLIPYDBGD-MLZQUWKJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENALAPRILAT","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL577","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enalaprilat","Vasotec"],"synonyms":["Enalapril diacid dihydrate","Enalapril diacid dihydrate anhydrous","Enalaprilat","Enalaprilat dihydrate","MK-422","NSC-760053","Vasotec i.v."],"crossReferences":{"DailyMed":["enalaprilat"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0000407","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989822","canonicalSmiles":"O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+]","inchiKey":"PJAHUDTUZRZBKM-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM CITRATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200458","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cymaclear","Effercitrate","Pot cit","Pot cit eff","Potassium citrate","Urocit-k","Urocit-k 5meq"],"synonyms":["K-cit-v","Kalii citras","Potassium citrate"],"crossReferences":{"DailyMed":["potassium%20citrate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for renal tubular acidosis."}
{"id":"CHEMBL3989887","canonicalSmiles":"C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC.O","inchiKey":"NWJQLQGQZSIBAF-MLAUYUEBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TACROLIMUS","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL269732","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adoport","Advagraf","Astagraf xl","Capexion","Envarsus","Envarsus xr","Modigraf","Perixis","Prograf","Protopic","Tacni","Tacrolimus","Vivadex"],"synonyms":["FK 506","FR900506","Tacrolimus","Tacrolimus hydrate"],"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["HP_0000964","EFO_0000540"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for eczema and immune system disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989967","canonicalSmiles":"CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1","inchiKey":"BBTFKAOFCSOZMB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOTAMILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-6005","E6005","Lotamilast","RVT-501"],"crossReferences":{"drugbank":["DB12776"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["EFO_0000274"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL399043","canonicalSmiles":"C=C/C(C)=C/[C@@]1(C)SC(=O)C(C)=C1O","inchiKey":"SYQNUQSGEWNWKV-XUIVZRPNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOLACTOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(5R)-Thiolactomycin","(R)-(+)-Thiolactomycin","5R-Thiolactomycin","Thiolactomycin"],"crossReferences":{"PubChem":["50106765","50106766","90341102"],"drugbank":["DB04302"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4163691","canonicalSmiles":"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1","inchiKey":"LZMJNVRJMFMYQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POSELTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HM71224","LY3337641","Ly3337641","Poseltinib"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4249337","canonicalSmiles":"Nc1nc2cc(CC[C@H]3C[C@@H](n4ccc5c(N)ncnc54)[C@H](O)[C@@H]3O)ccc2cc1Br","inchiKey":"DBSMLQTUDJVICQ-CJODITQLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONAMETOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-64619178","Jnj-64619178","Onametostat"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4296683","canonicalSmiles":"CCCCCCCCC/C=C/C=C/C(=O)NCC(=O)N[C@H]1[C@H]([C@@H](O)CO)O[C@H](Nc2ncnc3nc[nH]c23)[C@H](O)[C@@H]1O","inchiKey":"LQIPDFIUPOYMPR-BKYURJJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4296683","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15215"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297411","canonicalSmiles":"Nc1c2c(nc3c1CCCC3)CCCC2.O=C(O)CCC(=O)O","inchiKey":"SXNZJEKZKUJFLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTAHYDROAMINOACRIDINE SUCCINATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL263198","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octahydroaminoacridine succinate","Octohydroaminoacridine succinate"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297849","canonicalSmiles":"C[C@@H]1CN(c2nc(-n3ccc(OCCC4(C(F)(F)F)CC4)n3)ccc2C(=O)NS(=O)(=O)c2ccccc2)C(C)(C)C1","inchiKey":"IGEOJNMYRZUKIK-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAMOCAFTOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bamocaftor","VX-659","VX659","Vx-659"],"crossReferences":{"drugbank":["DB15177"]},"childChemblIds":["CHEMBL4298159"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297897","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"RADAVIRSEN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVI-7100","Avi-7100","Radavirsen"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297981","drugType":"Enzyme","blackBoxWarning":false,"name":"IMLIFIDASE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["HMED-IdeS","Hmed-ides","IdeS","Ides recombinant","Imlifidase"],"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) and is indicated for immune system disease and has 4 investigational indications."}
{"id":"CHEMBL4298076","drugType":"Unknown","blackBoxWarning":false,"name":"BEVIFIMOD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevifimod","Iggsorb","PRTX-100","Pansorbin","Protein a","Prtx-100"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL441343","canonicalSmiles":"O=C(O)c1ccc(O)cc1","inchiKey":"FJKROLUGYXJWQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Para-hydroxybenzoic acid","p-Hydroxybenzoic Acid","paraben"],"crossReferences":{"PubChem":["144209540","144213618"],"Wikipedia":["4-Hydroxybenzoic_acid"],"drugbank":["DB04242"],"chEBI":["30763"]},"childChemblIds":["CHEMBL1762656"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL445236","canonicalSmiles":"CC(=O)NC(=N)NCCC[C@@H]1NC(=O)[C@H](CCCC(=O)O)NC(=O)[C@H](Cc2c[nH]cn2)N2C(=O)[C@H](C[C@H]2O)NC(=O)[C@H]2CCCN2C1=O","inchiKey":"FOZYKTUSOWWQGR-KNPYFFGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGADIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Argadin"],"crossReferences":{"Wikipedia":["Argadin"],"drugbank":["DB04350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL452587","canonicalSmiles":"C[C@](O)(c1ccc(C(=O)N(C2CC2)[C@H]2CC[C@H](c3cccnc3)CC2)cc1)C(F)(F)F","inchiKey":"FLRYWTWLHWACRP-GRWTVWFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL452587","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07619"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594530","drugType":"Antibody","blackBoxWarning":false,"name":"TILVESTAMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-149","BGB149","Bgb149","Tilvestamab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL461101","canonicalSmiles":"CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\\Nc1cccc(-c2cccc(C(=O)O)c2)c1O","inchiKey":"XDXWLKQMMKQXPV-QYQHSDTDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ELTROMBOPAG","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Revolade"],"synonyms":["Eltrombopag","SB497115"],"crossReferences":{"DailyMed":["eltrombopag%20olamine"],"Wikipedia":["Eltrombopag"],"drugbank":["DB06210"],"chEBI":["85010"]},"childChemblIds":["CHEMBL461805","CHEMBL3989691","CHEMBL461806"],"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","Orphanet_84","EFO_0000637","EFO_0001642","EFO_0000222","HP_0001915","Orphanet_182050","HP_0001873","EFO_0004599","EFO_0000565","EFO_0001422","EFO_0007160","EFO_0004220","MP_0001914","EFO_0006926","Orphanet_906","EFO_0000095","EFO_0006927","EFO_0001421","EFO_0000574","EFO_0004272","EFO_0001378","EFO_0003047","MONDO_0002245"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 5 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4650384","drugType":"Unknown","blackBoxWarning":false,"name":"CALCIUM SODIUM PHOSPHOSILICATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["45s5 bioglass","Calcium sodium phosphosilicate","Novamin","Perioglas"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650393","drugType":"Antibody","blackBoxWarning":false,"name":"EPCORITAMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epcoritamab"],"linkedTargets":{"rows":["ENSG00000156738","ENSG00000167286","ENSG00000160654","ENSG00000198851"],"count":4},"linkedDiseases":{"rows":["EFO_0000096","EFO_0000095","EFO_0000403","EFO_0005952","MONDO_0002083"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL471","canonicalSmiles":"CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1","inchiKey":"ZBMZVLHSJCTVON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SOTALOL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betapace","C07AA07","Darob mite","Dl-sotalol","MJ-1999","Sorine","Sotalol"],"crossReferences":{"DailyMed":["sotalol%20hydrochloride"],"PubChem":["144203812","26751989"],"Wikipedia":["Sotalol"],"drugbank":["DB00489"],"chEBI":["63622"]},"childChemblIds":["CHEMBL1700"],"linkedTargets":{"rows":["ENSG00000055118","ENSG00000169252","ENSG00000043591"],"count":3},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0004287","EFO_0003144","EFO_0005306","HP_0004308","EFO_0004278","EFO_0000319","EFO_0000612"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and is indicated for ventricular arrhythmia and cardiovascular disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL477","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"OIRDTQYFTABQOQ-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADENOSINE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adenocard","Adenocor","Adenoscan","Adenosine"],"synonyms":["9-.beta.-d-ribofuranosyladenine","Adenosine","NSC-7652","SR 96225","SR-96225"],"crossReferences":{"DailyMed":["adenosine"],"PubChem":["144204442","170465447","26751564","50104175","855932","90341699"],"Wikipedia":["Adenosine"],"drugbank":["DB00640"],"chEBI":["16335"]},"linkedTargets":{"rows":["ENSG00000282608","ENSG00000170425","ENSG00000128271","ENSG00000163485"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000275","EFO_0000318","EFO_0001645","EFO_0000556","EFO_0000319","EFO_1000637","EFO_0003843","EFO_0000537","EFO_0003913","EFO_0000311","MP_0001845","EFO_0009493","EFO_1001450","EFO_0008585","EFO_1001375","EFO_0000095","EFO_1002000","EFO_0005306","HP_0004755","EFO_0008583","EFO_0000612","EFO_1000882","EFO_0005672"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 3 approved and 17 investigational indications."}
{"id":"CHEMBL52606","canonicalSmiles":"C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C","inchiKey":"OHCQJHSOBUTRHG-KGGHGJDLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COLFORSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Boforsin","Colforsin","Forskolin","HL 362","HL-362","L 75 1362B","L-75-1362B","L-751362B","NSC-357088","NSC-375489"],"crossReferences":{"PubChem":["144204491","144212716","170466094","26752068","29215035","47193715","56320676"],"Wikipedia":["Forskolin"],"drugbank":["DB02587"],"chEBI":["42471"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539204","canonicalSmiles":"O=S(=O)(O)CCNCl","inchiKey":"NMMHHSLZJLPMEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-Chlorotaurine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-Chlorotaurine"],"crossReferences":{"drugbank":["DB06633"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL53950","canonicalSmiles":"O=P(O)(O)C(NC1CCCCCC1)P(=O)(O)O","inchiKey":"LWRDQHOZTAOILO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INCADRONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Incadronic acid","NSC-723271"],"crossReferences":{"drugbank":["DB06255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL71733","canonicalSmiles":"C[n+]1cccc(C(N)=O)c1","inchiKey":"LDHMAVIPBRSVRG-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIGONELLAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-mna","Tria-662","Trigonellamide","Trigonellinamide"],"crossReferences":{"drugbank":["DB11710"],"chEBI":["16797"]},"childChemblIds":["CHEMBL1209652"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL94809","canonicalSmiles":"CCCCCCCCCCCCCCCCS(=O)(=O)F","inchiKey":"QIVFMUVBIHIZAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXADECANESULFONYL FLUORIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexadecanesulfonyl Fluoride","Palmitylsulfonyl Fluoride"],"crossReferences":{"drugbank":["DB02035"],"chEBI":["43275"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL967","canonicalSmiles":"CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"SEQDDYPDSLOBDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TEMAZEPAM","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kentepam","Normison","Restoril","Temaz","Temazepam"],"synonyms":["(rs)-temazepam","NSC-246303","Temazepam","Temazepam civ","WY-3917"],"crossReferences":{"DailyMed":["temazepam"],"PubChem":["144205223","144207242","29215382"],"Wikipedia":["Temazepam"],"drugbank":["DB00231"],"chEBI":["9435"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0000341","EFO_0005230","EFO_0004698"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for insomnia and has 5 investigational indications. This drug has a black box warning from the FDA."}
